---
title: "Phio Pharmaceuticals (PHIO) Surges 9% in After-Hours Trading on INTASYL Patent Approvals"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292819678.md"
description: "Phio Pharmaceuticals (PHIO) rose 9% after hours after announcing INTASYL patent approvals in the US, Canada, and Japan."
datetime: "2026-07-15T21:31:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292819678.md)
  - [en](https://longbridge.com/en/news/292819678.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292819678.md)
---

# Phio Pharmaceuticals (PHIO) Surges 9% in After-Hours Trading on INTASYL Patent Approvals

Phio Pharmaceuticals(PHIO.US) 盘后涨**8.79%**，现报**0.916**美元。

公司近日宣布其 INTASYL 化合物在美国、加拿大和日本获得专利批准，标志着知识产权组合取得重大进展。此次专利获批增强了公司在全球范围内的专利保护，目前已有 54 项涉及 INTASYL 化学和免疫肿瘤靶点的已授权专利。

### Related Stocks

- [PHIO.US](https://longbridge.com/en/quote/PHIO.US.md)

## Related News & Research

- [Phio Pharma wins U.S. patent allowance for BRD4-targeting INTASYL compound PH-894](https://longbridge.com/en/news/295525767.md)
- [Phio net loss widens to $4.14 million in Q2 FY26](https://longbridge.com/en/news/295141049.md)
- [Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026 | PHIO Stock News](https://longbridge.com/en/news/282184588.md)
- [03:07 ETHot off the Press: Recent Publications from Improved Pharma and Varda Space Industries Collaboration](https://longbridge.com/en/news/285165527.md)